Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
12.68
+0.08 (0.63%)
Nov 17, 2025, 11:38 AM EST - Market open
RGC Market Cap
RGC has a market cap or net worth of $6.27 billion as of November 17, 2025. Its market cap has increased by 6,873.09% in one year.
Market Cap
6.27B
Enterprise Value
6.31B
1-Year Change
6,873.09%
Ranking
Category
Stock Price
$12.68
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $6.27B, an increase of 5,120.75%. That is a compound annual growth rate of 149.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 6.23B | 9,592.31% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 921.47B |
| Johnson & Johnson | 473.62B |
| AbbVie | 413.00B |
| UnitedHealth Group | 292.81B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 232.52B |
| Abbott Laboratories | 226.78B |